Home
Ishita Drugs & Industries Ltd PE Ratio

Ishita Drugs & Industries Ltd
NSE: ISHITADRUGS
PE
Key Highlights
- The P/E Ratio of Ishita Drugs & Industries Ltd is 27.7 as of 19 Apr 9.00 AM .
- The P/E Ratio of Ishita Drugs & Industries Ltd changed from 6 on March 2020 to 26.2 on March 2024 . This represents a CAGR of 34.29% over 5 years.
- The Latest Trading Price of Ishita Drugs & Industries Ltd is ₹ 79.9 as of 17 Apr 15:30 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.9. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 159.2. The PE Ratio of Textiles industry is 37.1 in 2024.
Historical P/E Ratio of Ishita Drugs & Industries Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Ishita Drugs & Industries Ltd
Company Fundamentals for Ishita Drugs & Industries Ltd

Ishita Drugs & Industries Ltd
NSE: ISHITADRUGS
Share Price
Market Price of Ishita Drugs & Industries Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
17 Apr 2025 | 79.9 |
16 Apr 2025 | 80 |
15 Apr 2025 | 80.11 |
11 Apr 2025 | 82.3 |
09 Apr 2025 | 82.67 |
08 Apr 2025 | 81.11 |
07 Apr 2025 | 82.83 |
04 Apr 2025 | 81.07 |
03 Apr 2025 | 84.61 |
02 Apr 2025 | 85.18 |
BlinkX Score for Ishita Drugs & Industries Ltd
Asset Value vs Market Value of Ishita Drugs & Industries Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Ishita Drugs & Industries Ltd | 23.89 | 27.74 |
Sun Pharmaceutical Industries Ltd | 420136 | 35.6 |
Divis Laboratories Ltd | 149680 | 72.4 |
Cipla Ltd | 122390 | 24.5 |
Torrent Pharmaceuticals Ltd | 110154 | 59.2 |
Mankind Pharma Ltd | 106555 | 52.2 |
Company | |
---|---|
Ishita Drugs & Industries Ltd | 23.89 |
Sun Pharmaceutical Industries Ltd | 420136 |
Divis Laboratories Ltd | 149680 |
Cipla Ltd | 122390 |
Torrent Pharmaceuticals Ltd | 110154 |
Mankind Pharma Ltd | 106555 |
PE Ratio of Ishita Drugs & Industries Ltd Explained
₹23.89
Market cap
₹0
Earnings
27.7X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Ishita Drugs & Industries Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Ishita Drugs & Industries Ltd
Historical Revenue, EBITDA and Net Profit of Ishita Drugs & Industries Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Ishita Drugs & Industries Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Ishita Drugs & Industries Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Ishita Drugs & Industries Ltd
About Ishita Drugs & Industries Ltd
- Ishita Drugs & Industries Limited was incorporated in Feb.'92 by Jagdish Agarwal.
- The Company is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemicals and excipient.
- It has a state-of-art manufacturing facility, in terms of reaction capabilities, quality control and environmental safety.
- The plant has been designed and constructed to meet GMP norms. The genesis of the Ishita Group in 1992 was the result of the entrepreneurial spirit of Mr. Jagdish Agrawal, who set up a reactive dye manufacturing unit in Ahmedabad.
- Buoyed by the growth of its first Venture, the Group made its maiden foray in the pharma sector in 1981 by setting up a small Bulk drugs plant at Surendranagar in Gujarat, to cater to the need of Pharma industry for Quality Products.
Ishita Drugs & Industries Ltd News Hub
Ishita Drugs & Industries standalone net profit rises 7.14% in the June 2024 quarter
Net profit of Ishita Drugs & Industries rose 7.14% to Rs 0.15 crore in the quarter ended June 2024 a
Read more
14 Aug 24
Ishita Drugs & Industries to declare Quarterly Result
Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 13 August
Read more
10 Aug 24
Ishita Drugs & Industries AGM scheduled
Ishita Drugs & Industries announced that the Annual General Meeting (AGM) of the company will be hel
Read more
28 Aug 24
Ishita Drugs & Industries standalone net profit declines 9.52% in the September 2024 quarter
Net profit of Ishita Drugs & Industries declined 9.52% to Rs 0.19 crore in the quarter ended Septemb
Read more
13 Nov 24